Creative Biomolecules Overview

  • Year Founded
  • 1982

Year Founded

  • Status
  • Acquired/​Merged

  • Employees
  • 40

Employees

  • Latest Deal Type
  • M&A

Creative Biomolecules General Information

Description

Operator of a biopharmaceutical company focused on the discovery and development of therapies for human tissue regeneration and repair. The Company's therapies are based on bone morphogenetic proteins (BMPs) that act in initiating and regulating the cellular events involved in the development and repair of human tissues and organs. Its bone graft substitute is designed to promote new bone growth to heal severe fractures.

Contact Information

Formerly Known As
Creative Biomolecules Incorporated
Ownership Status
Acquired/Merged
Financing Status
Formerly VC-backed
Corporate Office
  • 45 South Street
  • Hopkinton, MA 01748
  • United States
+1 (508)
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Acquirer
Corporate Office
  • 45 South Street
  • Hopkinton, MA 01748
  • United States
+1 (508)

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Creative Biomolecules Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
7. Merger/Acquisition 31-Jul-2000 Completed Profitable
6. PIPE 29-May-1998 Completed Profitable
5. 2PO 03-Jul-1996 Completed Profitable
4. IPO 01-Dec-1992 Completed Profitable
3. Later Stage VC 30-Oct-1991 Completed Generating Revenue
2. Later Stage VC 04-Sep-1989 $7.5M $10.2M Completed Generating Revenue
1. Later Stage VC 18-May-1987 $2.7M $2.7M Completed Generating Revenue
To view Creative Biomolecules’s complete valuation and funding history, request access »

Creative Biomolecules Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Operator of a biopharmaceutical company focused on the discovery and development of therapies for human tissue regenerat
Drug Discovery
Hopkinton, MA
40 As of 1999

Antwerp, Belgium
 

Plymouth Meeting, PA
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Creative Biomolecules Competitors (9)

One of Creative Biomolecules’s 9 competitors is Agomab Therapeutics, a Formerly VC-backed company based in Antwerp, Belgium.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Agomab Therapeutics Formerly VC-backed Antwerp, Belgium
Inovio Pharmaceuticals Corporation Plymouth Meeting, PA
Sangamo Therapeutics Formerly VC-backed Richmond, CA
GeneCast Biotechnology Private Equity-Backed Wuxi, China
Cellmade Private Equity-Backed Ruffieux, France
You’re viewing 5 of 9 competitors. Get the full list »

Creative Biomolecules Patents

Creative Biomolecules Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-20080167225-A1 Providing an osteogenic protein in a biocompatible bioresorbable carrier to defect locus, thereby inducing formation of functional replacement cartilage tissue, repairing a defect in an intervertebral disc Active 30-Jul-1999
US-7572440-B2 Providing an osteogenic protein in a biocompatible bioresorbable carrier to defect locus, thereby inducing formation of functional replacement cartilage tissue, repairing a defect in an intervertebral disc Inactive 30-Jul-1999
WO-2000066620-A2 Morphogen-induced enhancement of fertility Inactive 30-Apr-1999
WO-2000066620-A3 Morphogen-induced enhancement of fertility Inactive 30-Apr-1999
WO-2000029012-A2 Methods of alleviating cancer symptoms Inactive 13-Nov-1998 C07K14/51
To view Creative Biomolecules’s complete patent history, request access »

Creative Biomolecules Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Creative Biomolecules Former Investors (5)

Investor Name Investor Type Holding Investor Since Participating Rounds
Apax Partners PE/Buyout Minority
Banexi Ventures Partners Venture Capital Minority
Diaz & Altschul Advisors Corporate Venture Capital Minority
Domain Associates Venture Capital Minority
Marion Laboratories Corporation Minority
To view Creative Biomolecules’s complete investors history, request access »

Creative Biomolecules Investments & Acquisitions (2)

Creative Biomolecules’s most recent deal was a Reverse Merger with Curis. The deal was made on 31-Jul-2000.

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
Curis 31-Jul-2000 Reverse Merger Biotechnology
Exelixis 01-Mar-1995 Early Stage VC Drug Discovery
To view Creative Biomolecules’s complete investments and acquisitions history, request access »

Creative Biomolecules FAQs

  • When was Creative Biomolecules founded?

    Creative Biomolecules was founded in 1982.

  • Where is Creative Biomolecules headquartered?

    Creative Biomolecules is headquartered in Hopkinton, MA.

  • What is the size of Creative Biomolecules?

    Creative Biomolecules has 40 total employees.

  • What industry is Creative Biomolecules in?

    Creative Biomolecules’s primary industry is Drug Discovery.

  • Is Creative Biomolecules a private or public company?

    Creative Biomolecules is a Private company.

  • What is Creative Biomolecules’s current revenue?

    The current revenue for Creative Biomolecules is .

  • How much funding has Creative Biomolecules raised over time?

    Creative Biomolecules has raised $85.7M.

  • Who are Creative Biomolecules’s investors?

    Apax Partners, Banexi Ventures Partners, Diaz & Altschul Advisors, Domain Associates, and Marion Laboratories have invested in Creative Biomolecules.

  • Who are Creative Biomolecules’s competitors?

    Agomab Therapeutics, Inovio Pharmaceuticals, Sangamo Therapeutics, GeneCast Biotechnology, and Cellmade are some of the 9 competitors of Creative Biomolecules.

  • When was Creative Biomolecules acquired?

    Creative Biomolecules was acquired on 31-Jul-2000.

  • Who acquired Creative Biomolecules?

    Creative Biomolecules was acquired by Curis.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process